<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) encodes oncogenic information and, oftentimes concomitant with host immunosuppression, gives rise to <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> major categories of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> defined by the World Health Organization </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we conditionally evicted the <z:mp ids='MP_0001799'>viral</z:mp> extrachromosomal genome from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in vitro to examine the role of EBV in different <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, including Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and posttransplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Cells derived from 2 canonical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> were found to have the least dependence on the virus; some required EBV to prevent the inefficient induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, cells derived from a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, Wp-restricted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, required EBV to block a robust apoptotic program that involves the up-regulation of the proapoptotic protein <z:chebi fb="3" ids="33173">Bim</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Wp-restricted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells also relied on the virus to promote efficient proliferation, a distinction that highlights the multiple contributions EBV makes to affect proliferation of its host cells </plain></SENT>
<SENT sid="5" pm="."><plain>Like Wp-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells, posttransplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> cells depended on the virus to inhibit <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>They furthermore required the virus to drive them out of G(1)/G(0) </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these results reveal a graded dependence on EBV among <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells that directly correlates with the number of <z:mp ids='MP_0001799'>viral</z:mp> genes expressed in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell </plain></SENT>
</text></document>